| Emily Claire Larson, DO | |
|
802 N Riverside Rd, Suite 140, Saint Joseph, MO 64507-2502 | |
| (816) 271-7979 | |
| (816) 271-7971 |
| Full Name | Emily Claire Larson |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 17 Years |
| Location | 802 N Riverside Rd, Saint Joseph, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417154063 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 2010017411 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mosaic Life Care At St Joseph | Saint joseph, MO | Hospital |
| Carroll County Memorial Hospital | Carrollton, MO | Hospital |
| Lafayette Regional Health Center | Lexington, MO | Hospital |
| Ssm Health St. Francis Hospital- Maryville | Maryville, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midwest Division - Lrhc Llc | 0941119150 | 34 |
| Carroll County Memorial Hospital | 2860485638 | 55 |
| Heartland Regional Medical Center | 6709772767 | 342 |
News Archive
Ampio Pharmaceuticals, Inc., a biopharmaceutical company conducting clinical trials on its three lead drugs (Zertane completed two phase III studies, Ampion-completed proof of concept studies and Optina), licensing distribution of these drugs and engaged in further drug development, today announced that it completed the planned interim review of the first 50% of patients enrolled in the Optina trial for diabetic macular edema.
A new study has tried to assess the genetic variants among mosquitoes that make them more susceptible to spreading deadly viral diseases such as dengue, yellow fever, Zika and chikungunya and more resistant to insecticides that are used to kill them.
Research led by Dr. Suresh Alahari, Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, is the first to report that two specific tumor suppressor genes work in concert to inhibit the growth and spread of breast tumor cells to the lungs.
The University of Maryland School of Medicine, University of Maryland Medical Center, and the Tuberous Sclerosis Alliance have joined together to launch first-of-a-kind centers in Maryland to treat adults with neurodevelopmental disabilities, such as autism.
Results from a large study show that diastolic hypotension is a consistent predictor of admission to hospital in all children with asthma.
› Verified 7 days ago
| Entity Name | Midwest Division - Lrhc Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639362460 PECOS PAC ID: 0941119150 Enrollment ID: O20031105000738 |
News Archive
Ampio Pharmaceuticals, Inc., a biopharmaceutical company conducting clinical trials on its three lead drugs (Zertane completed two phase III studies, Ampion-completed proof of concept studies and Optina), licensing distribution of these drugs and engaged in further drug development, today announced that it completed the planned interim review of the first 50% of patients enrolled in the Optina trial for diabetic macular edema.
A new study has tried to assess the genetic variants among mosquitoes that make them more susceptible to spreading deadly viral diseases such as dengue, yellow fever, Zika and chikungunya and more resistant to insecticides that are used to kill them.
Research led by Dr. Suresh Alahari, Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, is the first to report that two specific tumor suppressor genes work in concert to inhibit the growth and spread of breast tumor cells to the lungs.
The University of Maryland School of Medicine, University of Maryland Medical Center, and the Tuberous Sclerosis Alliance have joined together to launch first-of-a-kind centers in Maryland to treat adults with neurodevelopmental disabilities, such as autism.
Results from a large study show that diastolic hypotension is a consistent predictor of admission to hospital in all children with asthma.
› Verified 7 days ago
| Entity Name | Heartland Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477575405 PECOS PAC ID: 6709772767 Enrollment ID: O20040225001201 |
News Archive
Ampio Pharmaceuticals, Inc., a biopharmaceutical company conducting clinical trials on its three lead drugs (Zertane completed two phase III studies, Ampion-completed proof of concept studies and Optina), licensing distribution of these drugs and engaged in further drug development, today announced that it completed the planned interim review of the first 50% of patients enrolled in the Optina trial for diabetic macular edema.
A new study has tried to assess the genetic variants among mosquitoes that make them more susceptible to spreading deadly viral diseases such as dengue, yellow fever, Zika and chikungunya and more resistant to insecticides that are used to kill them.
Research led by Dr. Suresh Alahari, Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, is the first to report that two specific tumor suppressor genes work in concert to inhibit the growth and spread of breast tumor cells to the lungs.
The University of Maryland School of Medicine, University of Maryland Medical Center, and the Tuberous Sclerosis Alliance have joined together to launch first-of-a-kind centers in Maryland to treat adults with neurodevelopmental disabilities, such as autism.
Results from a large study show that diastolic hypotension is a consistent predictor of admission to hospital in all children with asthma.
› Verified 7 days ago
| Entity Name | Carroll County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528067113 PECOS PAC ID: 2860485638 Enrollment ID: O20040407000120 |
News Archive
Ampio Pharmaceuticals, Inc., a biopharmaceutical company conducting clinical trials on its three lead drugs (Zertane completed two phase III studies, Ampion-completed proof of concept studies and Optina), licensing distribution of these drugs and engaged in further drug development, today announced that it completed the planned interim review of the first 50% of patients enrolled in the Optina trial for diabetic macular edema.
A new study has tried to assess the genetic variants among mosquitoes that make them more susceptible to spreading deadly viral diseases such as dengue, yellow fever, Zika and chikungunya and more resistant to insecticides that are used to kill them.
Research led by Dr. Suresh Alahari, Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, is the first to report that two specific tumor suppressor genes work in concert to inhibit the growth and spread of breast tumor cells to the lungs.
The University of Maryland School of Medicine, University of Maryland Medical Center, and the Tuberous Sclerosis Alliance have joined together to launch first-of-a-kind centers in Maryland to treat adults with neurodevelopmental disabilities, such as autism.
Results from a large study show that diastolic hypotension is a consistent predictor of admission to hospital in all children with asthma.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Claire Larson, DO 802 N Riverside Rd, Suite 140, Saint Joseph, MO 64507-2502 Ph: (816) 271-7979 | Emily Claire Larson, DO 802 N Riverside Rd, Suite 140, Saint Joseph, MO 64507-2502 Ph: (816) 271-7979 |
News Archive
Ampio Pharmaceuticals, Inc., a biopharmaceutical company conducting clinical trials on its three lead drugs (Zertane completed two phase III studies, Ampion-completed proof of concept studies and Optina), licensing distribution of these drugs and engaged in further drug development, today announced that it completed the planned interim review of the first 50% of patients enrolled in the Optina trial for diabetic macular edema.
A new study has tried to assess the genetic variants among mosquitoes that make them more susceptible to spreading deadly viral diseases such as dengue, yellow fever, Zika and chikungunya and more resistant to insecticides that are used to kill them.
Research led by Dr. Suresh Alahari, Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, is the first to report that two specific tumor suppressor genes work in concert to inhibit the growth and spread of breast tumor cells to the lungs.
The University of Maryland School of Medicine, University of Maryland Medical Center, and the Tuberous Sclerosis Alliance have joined together to launch first-of-a-kind centers in Maryland to treat adults with neurodevelopmental disabilities, such as autism.
Results from a large study show that diastolic hypotension is a consistent predictor of admission to hospital in all children with asthma.
› Verified 7 days ago
Dr. Andre Joel Arsenault, M.D Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5325 Faraon St, Saint Joseph, MO 64506 Phone: 816-271-6406 Fax: 816-271-7986 | |
Robert C Clark, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 901 Heartland Rd, Ste 3800, Saint Joseph, MO 64506 Phone: 816-671-4800 Fax: 816-233-4021 | |
Issam El Bizri, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5325 Faraon St, Saint Joseph, MO 64506 Phone: 816-271-6406 Fax: 816-271-7986 | |
Bradley R Dyer, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5325 Faraon St, Ms 1020 Division Of General And Geriatric Medicine Univ, Saint Joseph, MO 64506 Phone: 816-271-6406 | |
Gita G Sprague, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5514 Corporate Dr Ste 120, Saint Joseph, MO 64507 Phone: 816-271-1350 Fax: 816-271-1355 | |
Federico Rivas-gotz, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 5514 Corporate Dr Ste 120, Saint Joseph, MO 64507 Phone: 816-271-1350 Fax: 816-271-1355 | |
Dr. Vijay Kanakadandi, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 802 N Riverside Rd Ste 220, Saint Joseph, MO 64507 Phone: 816-271-6155 |